The endothelium as a metabolic and endocrine organ: Its relation with insulin resistance

Experimental and Clinical Endocrinology and Diabetes

Volumn 109, Issue SUPPL. 2, 2001, Pages

  Baumgartner Parzer, S M ^a   Waldhausl W K ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Adhesion molecules; Diabetes; Endocrine organ; Endothelium; Insulin resistance; Metabolism; Vasoactive molecules

Indexed keywords

BLOOD CLOTTING FACTOR; CELL ADHESION MOLECULE; CYTOKINE; CYTOKINE RECEPTOR; GROWTH FACTOR; GROWTH FACTOR RECEPTOR; HORMONE RECEPTOR; PEPTIDE HORMONE; VASOACTIVE AGENT;

APOPTOSIS; ARTICLE; BLOOD CLOTTING; CELL PROLIFERATION; DIABETES MELLITUS; DYSLIPIDEMIA; ENDOCRINE GLAND; FIBRINOLYSIS; HUMAN; HYPERTENSION; INSULIN RESISTANCE; LEUKOCYTE ADHERENCE; LEUKOCYTE MIGRATION; NONHUMAN; OBESITY; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM; VASOCONSTRICTION; VASODILATATION;

ANIMALS; BLOOD COAGULATION FACTORS; CELL ADHESION MOLECULES; CYTOKINES; ENDOCRINE GLANDS; ENDOTHELIUM, VASCULAR; HORMONES; HUMANS; INSULIN RESISTANCE; VASOCONSTRICTION; VASODILATION;

EID: 0034975217     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-18579     Document Type: Article

References (100)

1. Impaired endothelium dependent vasodilation in women with previous gestational diabetes
2. Diabetes and obesity
3. Forearm nitric oxide balance, vascular relaxation, and glucose metabolism in NIDDM patients
4. Endothelial function, insulin sensitivity, and hypertension
5. Mechanism of insulin resistance in insulin-dependent diabetes mellitus: A major role for reduced skeletal muscle flow
6. Insulin mediated skeletal muscle dilation contributes to both insulin sensitivity and responsiveness in lean humans
7. Insulin and the vasculature-old actors, new roles
8. Stimulation of endothelin-1 production by thrombin, but lack of interference by high ambient glucose in vitro
9. Modulation by high glucose of adhesion molecule expression
10. High-glucosetriggered apoptosis in cultured endothelial cells
11. High glucose does not affect endothelin-1 synthesis or release by cultured human endothelial cells
12. Determination of plasma ET-1 by RIA - Risks and limitations
13. Role of oxidative stress in diabetic complications: A new perspective an old paradigm
14. Endothelial-leucocyte adhesion molecules
15. Effects of nitrovasodilators on platelet cyclic nucleotide levels in rabbit blood: Role for cyclic AMP in synergistic inhibition of platelet function by SIN-1 and prostaglandin E1
16. Modulation of the antioxidant defence as a factor in apoptosis
17. Advanced glycosylation endproducts in tissues and the biochemical basis of diabetic complications
18. Endothelial dysfunction in diabetes mellitus
19. Endothelial cell-to-cell junctions
20. Vascular endothelium
21. Nitric oxide - An endothelial survival factor
22. Structure and function of thrombomodulin: A natural anticoagulant
23. Proinflammatory cytokines and immunity
24. Abnormal markers of endothelial cell activation anc oxidative stress in children, adolescents and young adults with type-1-diabetes with no chemical vascular disease
25. Inhibition of nitric oxide synthesis in forearm vasculature of insulin dependent diabetic patients: Blunted vasoconstriction in patients with microalbuminuria
26. Metabolic effects of fish-oil supplementation in patients with impaired glucose tolerance
27. Elevated concentrations of circulating adhesion molecules and their association with microvascular complications in insulin-dependent diabetes mellitus (IDDM)
28. Role of lipid oxidation in pathogenesis of insulin resistance of obestiy and type-2-diabetes
29. Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus. Problems and prospects
30. Insulin stimulates endothelin-1 secretion from human endothelial cells and modulates is circulating levels in vivo
31. The pathophysiological role of platelets during myocardial ischemia
32. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine
33. Transforming growth factor β inhibits E-selectin expression on human endothelial cells
34. Oxidative stress and vascular complications
35. 2+/EDRF signalling are due to generation of superoxide anions
36. Mortality from coronary heart disease in subjects with type-2-diabetes and in nondiabetic subjects with and without prior myocardial infarction
37. Relatively more atherogenic coronary heart disease risk factors in prediabetic women than in prediabetic men
38. Effect of glucose and insulin on immunoreactive endothelin-1 release from cultured porcine aortic endothelial cells
39. Endothelin: Emerging role in diabetic vascular complications
40. Mechanisms of TNF-α-induced insulin resistance
41. Endothelium in insulin resistance and diabetes
42. Basic mechanism of leukocyte migration
43. Endothelium as an endocrine organ
44. Abnormality in prostacyclin stimulatory activity in the sera from diabetes
45. Platelet function in diabetes mellitus
46. The Bedford Survey: Ten years mortality rates in newly diagnosed diabetes, borderline diabetics and normoglycaemic controls and risk indices for coronary heart diseases in borderline diabetics
47. Impaired endothelium dependent vasodilation in patients with insulindependent diabetes mellitus
48. Plasma endothelin-1 levels in patients with diabetes mellitus with or without vascular complication
49. Effect of hyperosmolality on basal and hormone-stimulated hepatic glucose metabolism in vitro
50. Impaired insulin mediated skeletal muscle blood flow in patients with NIDDM
51. Vascular insulin resistance in hypertension
52. Cytokines, modified lipoproteins, and arteriosclerosis in Diabetes
53. Pathobiology of endothetial and other vascular cells in diabetes mellitus. Call for data
54. Endothelin1-21 plasma concentrations in children and adolescents with insulin dependent diabetes mellitus
55. Platelet activation
56. Role of endothelin in mechanisms of local blood pressure control
57. Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus
58. Nitric oxide: Physiology, pathophysiology and pharmacology
59. Impairment of coronary artery reserve and Ach-induced coronary vasodilation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function
60. Stimulation of endothelin-1 gene expression by insulin in endothelial cells
61. Review of alterations in endothelial nitric oxide production in diabetes
62. Long-term treatment in vivo with NOX-101, a scavenger of nitric oxide, prevents diabetes-induced endothelial dysfunction
63. Reversal by 1-arginine of a dysfunctional arginine/nitric oxide pathway in the endothelium of the genetic diabetic BB rat
64. Endothelial dysfunction: Cause of the insulin resistance syndrome
65. Endothelial cell function in diabetic microangiopathy
66. An 1-arginine/nitric oxide pathway present in human platelets regulates aggregation
67. Role of insulin resistance in human disease
68. Rapid impairment of skeletal muscle glucose transport/phosphorylation by free fatty acids in man
69. Integrin overexpression induced by high glucose and by human diabetes: Potential pathway to cell dysfunction in diabetic microangiopathy
70. Decreased muscle glucose transport/phosphorylation is an early defect in the pathogenesis of non-insulin-dependent diabetes mellitus
71. Biochemistry and genetics of von Willebrand factor
72. Angiotensin I converting enzyme and its role in neuropeptide metabolism
73. Endothelium dependent vascular relaxation in patients with type-1-diabetes
74. Adhesion receptors of the immune system
75. Vascular endothelial growth factor inhibits endothelial cell apoptosis induced by tumor necrosis factor-alpha: Balance between growth and death signals
76. The pathogenesis of vascular complications of diabetes mellitus: One voice or many?
77. Obesity/insulin resistance is associated with endothelial dysfunction
78. Proteoglycans on endothelial cells present adhesion-inducing cytokines to leukocytes
79. Elevated plasma endothelin in patients with diabetes mellitus
80. Nitric oxide attenuates adhesion molecule expression in human endothelial cells
81. Molecular mechanisms of insulin resistance
82. Elevated glucose impairs endothelium dependent relaxation by activating protein kinase C
83. Endotheliopathy precedes type-2-diabetes
84. The vascular endothelium in diabetes and hypertension
85. Regulatory functions of the vascular endothelium
86. Modulation of vascular smooth muscle contraction by the endothelium
87. Insulin resistance and the regulation of vascular tone: Is insulin a vasodilator?
88. Coronary risk factors, endothelial function and atherosclerosis: A review
89. Polar secretion of endothelin-1 by cultured endothelial cells
90. Increase of insulin sensitivity and improvement of intravenous glucose tolerance by fish oil in healthy man
91. Effect of stress hormones on splanchnic substrate and insulin disposal following glucose ingestion in healthy man
92. Platelet endothelium interactions
93. The vascular extracellular matrix
94. The oxdiation hypothesis of atherosclerosis
95. Enhanced secretion of endothelin-1 by elevated glucose levels from cultured bovine aortic endothelial cells
96. Glucose toxicity
97. Insulin induced vasodilatation: Physiology or pharmacology?
98. Insulin stimulated production of nitric oxide is inhibited by wortmannin: Direct measurement in vascular endothelial cells